The global pharmaceutical drug delivery devices market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are fuelling the global pharmaceutical drug delivery devices market include the increasing adoption of advanced technology for effectively delivering the drug on the target site, which is expected to drive the market growth during the forecast period. Moreover, usage of these drug delivery devices reduces the chances of side effects by optimizing the drug present at the target site. This helps in minimizing the dose and associated side effects. In addition, this helps in reducing the overall product price by reducing the amount of active pharmaceutical ingredients.

Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. Such devices are used as part of one or more medical treatments. Furthermore, the global pharmaceutical drug delivery devices market analysis includes some of the key market players such as Johnson & Johnson, Novartis International AG, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, and Antares Pharma, among others. To maintain a strong position in the market, the market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. 

Recent Development:

• In January 2019, AstraZeneca collaborated with Aptamer Group, a biotechnology company for exploring its technology to develop a novel drug delivery device for the kidney. In addition, the rising adoption of drug delivery devices in home-care settings is increasing the accessibility of these devices for patients.
• In October 2019, Phillips-Medisize, now the subsidiary of Molex Company, announced that they are going to launch a combination and an electronic enabled wearable drug delivery device. Currently, the product combines two-day, single-use, disposable technology for subcutaneous drug delivery and is currently in the post-phase three development stage.
• In October 2019, Aptar Pharma acquired Noble International and its training drug delivery devices. Noble International developed patient-centric advanced drug delivery training devices such as prefilled syringes and auto-injectors. This acquisition will help patients to properly administer medications through advanced drug delivery devices.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Johnson & Johnson Services, Inc., Novartis International AG, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, and Antares Pharma, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Pharmaceutical Drug Delivery Devices Market by Segment

By Route of Administration 

• Oral Drug Delivery

• Liquid Oral Drugs

• Injectable Drug Delivery

• Topical Drug Delivery

• Others

By Application 

• Cancer

• Diabetes

• Cardiovascular Diseases 

• Autoimmune Diseases

• Others

By Facility of Use 

• Hospitals

• Ambulatory Surgery Centers

• Home Care Settings

• Others

Global Pharmaceutical Drug Delivery Devices Market by Region